Though retinal detachment is more common among older people,
the average age of patients has been getting lower thanks to excessive cell phone use, Yu added.
Mainly, though, the diagnoses are more routine, at least until you consider that
the average age of her patients is under 40.
Some 29 percent of the patients were women and
the average age of all patients was 59.
The average age of the patients was 61 years and the average body mass index (BMI) was 40, which means that the person is about 100 pounds overweight.
The average age of patients ranged from 29.7 years to 35.8 years.
The average age of patients in the study group was 84.5 years, and many had additional serious health risks.
The average age of the patients was 61 years; 582 patients (33.1 percent) were 65 years or older and 123 patients (7 percent) were 75 years or older.
Ninety - five percent of the patients were women in both the «broken hearts» and «happy hearts» groups, and
the average age of patients was 65 among the «broken hearts» and 71 among the «happy hearts,» confirming that the majority of TTS cases occur in post-menopausal women.
The average age of the patients was 49, but their ages ranged from 22 to 91.
The average age of patients, though, is 10 years, according to Dr. Mark Peterson of the Animal Endocrine Clinic.
The average age of patients are 10.5 years with a higher incidence of the disease in Dachshunds, Cocker spaniels and Shepherd dogs.
Like other tumors,
the average age of the patient suffering from dog anal sac cancer or tumors is 10 years of age or older.
Not exact matches
The study population consisted
of 726
patients with an
average age of 79 years,
of whom 15 % had delirium (at admission or during the hospital stay).
Sixty percent
of the
patients were men and the
average age was 58 years.
This interim analysis included 60
patients, with an
average age of 68 years.
Patients had an
average disease duration
of 7 years and a mean
age of 47.
Most recently, they have taken mice in late middle
age and lengthened the remainder
of their lives by an
average of 30 to 40 percent with a drug called rapamycin, an antifungal agent also used to suppress immune responses in transplant
patients.
The study involved 412
patients,
average age 55.8, with confirmed cases
of cutaneous malignant melanoma.
A total
of 159
patients (
average age 77 years) with isolated systolic hypertension participated in the randomized clinical trial.
The study included 40
patients (24 women and 16 men with an
average age of nearly 50).
According to the nationally representative study,
patients who will gain Medicaid under expansion programs supported by the ACA will be younger (
average age of 36 versus 38), with a larger proportion being male (49 percent versus 33 percent) and white (60 percent versus 50 percent) compared to the current Medicaid population.
The
patients»
average age was 68.5 years; about three - fourths underwent THA because
of primary osteoarthritis.
Researchers examined data including nearly 90,000 privately insured U.S.
patients between
ages 13 and 21 (
averaging age 17) with no previous opioid prescriptions who underwent one
of 13 common surgeries for this
age group, compared with a control sample.
921
patients with an
average (median)
age of 70 to 71 years participated in this study worldwide.
Lead UK author on the study, Professor Stuart Elborn, Dean
of the School
of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, said: «The estimations we have made show very positive news for cystic fibrosis
patients as the
average survival
age is increasing.
Averaged over a four - year follow - up period, operatively treated
patients at least 80 years
of age, had significantly greater improvement in all primary and secondary outcome measures compared with
patients at least 80 years
of age who received nonsurgical treatment.
The heart
patients had been diagnosed before the
age of 55 (
average age 47), and admitted to one cardiac centre in eastern Indonesia.
The
average age in the study was around 80 years, and seven out
of ten
of the
patients were women.
The
patients were
ages 12 - 18 and had been ill with anorexia for an
average of 13.5 months.
The
patients included 79 males and 21 females with an
average age of 8.
The
patients averaged 62 years
of age; 60 percent
of the
patients were women.
During the same time period the
average age of hospitalized
patients increased from 38 to 46 years, with the percentage
of HAV - related hospitalizations covered by Medicare also increasing from 12 % to 23 %.
There were 738
patients (
average age about 74) without pre-ICH dementia who were included in the analyses
of early post-ICH dementia within six months.
Analyzing the baseline risk factors and health conditions
of patients in each grouping, they found the
average age of STEMI
patients decreased from 64 to 60, and the prevalence
of obesity increased from 31 to 40 percent between the first five - year span and the last five - year span.
Most
of the
patients were women; the
average age was 40 years.
In the trial, which took place in Denmark, 1,234
patients (
average age 61; 75 percent male) with acute STEMI symptoms
of less than 12 hours» duration were randomly assigned to receive standard angioplasty with immediate stent implantation or angioplasty followed by stent implantation after a re-examination 24 to 48 hours later.
The DANAMI - 3 iPOST trial, which took place in Denmark, included 1,234
patients (
average age 61; 79 percent male) with acute STEMI symptoms
of less than 12 hours» duration who were randomly assigned to receive standard angioplasty or ischemic postconditioning prior to stent implantation in the blocked artery.
Yet an extraordinary «natural experiment» in a Kansas mental hospital early this century found that
patients who were castrated (in the dubious hope
of controlling their violent behaviour) lived far longer — on
average to 69 years
of age whereas intact males managed a mere 56.
Roughly two - thirds
of patients studied were women, and the
average age was 60.
Over an 18 - year period, 98
patients (
average age 7.2 months) at two medical centers underwent a total
of 127 ES for 139 obstruction sites.
Patients were predominantly male,
average age of 27, with 6.5 years
of military service.
Of the 1,000
patients included in this analysis, 60 percent were male and the
average age was 61; 49 percent had cardiac disease, 41 percent diabetes, 30 percent chronic kidney disease and 17 percent sleep apnea.
On
average, these
patients were more likely to be male, middle -
aged, African - American and have a history
of cardiovascular disease, with a majority taking cardiovascular medication.
Of the 24 patients, 15 were male and nine female, with an average age of 47 year
Of the 24
patients, 15 were male and nine female, with an
average age of 47 year
of 47 years.
Ashikaga and his team used a basket - shaped catheter with 64 electrode sensors to measure the heart's electrical communication just before and right after the procedure, and again at six months in 22
patients with an
average age of about 64 years treated at the Johns Hopkins Hospital.
The
average patient age was 65.5 years old, and 61 percent
of patients were obese with a Body Mass Index (BMI)
of 33 kg / m ².
The team, led by Myra McClure, a professor
of retrovirology at Imperial College London, examined DNA from the blood
of 186 CFS
patients ranging in
age from 19 to 70, with an
average age of 40.
The
average patient age was 67, and the vast majority
of patients were white (87 percent), covered by Medicare (56.7 percent) and female (61 percent).
Patients younger than 65 years, had average progression - free survival times of 11.7 months (combination), 5.5 months (nivolumab) and 2.8 months (ipilimumab), while the 262 patients aged between 65 and 75 had average progression - free survival times of 11.1 months, 12.7 months and 2.9 months respe
Patients younger than 65 years, had
average progression - free survival times
of 11.7 months (combination), 5.5 months (nivolumab) and 2.8 months (ipilimumab), while the 262
patients aged between 65 and 75 had average progression - free survival times of 11.1 months, 12.7 months and 2.9 months respe
patients aged between 65 and 75 had
average progression - free survival times
of 11.1 months, 12.7 months and 2.9 months respectively.
In the pemetrexed alone group, there were 304
patients, 61.8 %
of whom were male, and the
average age was 64 years.